PTW
  • Users Online: 52
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
REVIEW ARTICLE
Year : 2021  |  Volume : 12  |  Issue : 3  |  Page : 96-99

Radiation therapy as an adjuvant treatment after breast-conserving surgery in ductal carcinoma In situ of the breast


Department of Radiation Oncology, Abderrahmen Mami Hospital, 2080, Ariana; University of Tunis El Manar, Faculty of Medicine of Tunis, 1007, Tunisia

Correspondence Address:
Dr. Raouia Ben Amor
Department of Radiation Oncology, Abderrahmen Mami Hospital, 2080, Ariana; University of Tunis El Manar, Faculty of Medicine of Tunis, 1007
Tunisia
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jrcr.jrcr_24_21

Rights and Permissions

Ductal carcinoma in situ (DCIS) of the breast is a nonmalignant tumor of the breast with a rising incidence due to systematic mammographic screening. Actual consensus on conservative therapy is based on lumpectomy followed by adjuvant radiation therapy to the whole breast. This approach has been established after multiple large clinical trials and confirmed with subsequent meta-analyses. However, there are still debates on the benefit of adjuvant radiation therapy in a largely undefined “low-risk population.” This review tries to discuss actual data on this matter and discuss the benefits and risks of radiation therapy after lumpectomy in DCIS.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed573    
    Printed24    
    Emailed0    
    PDF Downloaded58    
    Comments [Add]    

Recommend this journal